연구동향 분석

Detection of Plasma BRAFV600E Mutation Is Associated with Lung Metastasis in Papillary Thyroid Carcinomas

김보현 김인주 이병주 이진춘 김인숙 김성장 김원진 전윤경 김상수 김용기 2015년

논문상세정보
인용/피인용
' Detection of Plasma BRAFV600E Mutation Is Associated with Lung Metastasis in Papillary Thyroid Carcinomas' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • biomarker
  • braf
  • dna
  • papillary thyroid carcinoma
  • plasma
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,246 0

0.0%

' Detection of Plasma BRAFV600E Mutation Is Associated with Lung Metastasis in Papillary Thyroid Carcinomas' 의 참고문헌

  • 갑상선 유두암에서의 BRAF 변이와 예후인자와의 관계
    나소영 Endocrinology and Metabolism 20 (3) : 224 ~ 229 [2005]
  • 갑상선 유두암에서의 BRAF 변이와 예후인자와의 관계
    나소영 Endocrinology and Metabolism 20 3 224-229 [2005]
  • Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer
    Stulak JM Arch Surg 141 : 489 ~ 494 [2006]
  • Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer
    Stulak JM Arch Surg 141 489-494 [2006]
  • Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness
    Trovisco V Virchows Arch 446 : 589 ~ 595 [2005]
  • Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness
    Trovisco V Virchows Arch 446 589-595 [2005]
  • Thyroid cancer nodal metastases: biologic significance and therapeutic considerations
    Grebe SK Surg Oncol Clin N Am 5 : 43 ~ 63 [1996]
  • Thyroid cancer nodal metastases: biologic significance and therapeutic considerations
    Grebe SK Surg Oncol Clin N Am 5 43-63 [1996]
  • The prevalence and prognostic value of BRAF mutation in thyroid cancer
    Kebebew E Ann Surg 246 : 466 ~ 470 [2007]
  • The prevalence and prognostic value of BRAF mutation in thyroid cancer
    Kebebew E Ann Surg 246 466-470 [2007]
  • The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane
    Riesco-Eizaguirre G Endocr Relat Cancer 13 : 257 ~ 269 [2006]
  • The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane
    Riesco-Eizaguirre G Endocr Relat Cancer 13 257-269 [2006]
  • The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma
    Zaydfudim V Surgery 144 : 1070 ~ 1077 [2008]
  • The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma
    Zaydfudim V Surgery 144 1070-1077 [2008]
  • The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma
    Kim TY Clin Endocrinol (Oxf) 65 : 364 ~ 368 [2006]
  • The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma
    Kim TY Clin Endocrinol (Oxf) 65 364-368 [2006]
  • The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma
    Kim TY Clin Endocrinol (Oxf) 63 : 588 ~ 593 [2005]
  • The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma
    Kim TY Clin Endocrinol (Oxf) 63 588-593 [2005]
  • Pattern of nodal metastasis for primary and reoperative thyroid cancer
    Machens A World J Surg 26 : 22 ~ 28 [2002]
  • Pattern of nodal metastasis for primary and reoperative thyroid cancer
    Machens A World J Surg 26 22-28 [2002]
  • Mutations of the BRAF Gene in Papillary Thyroid Carcinoma in a Korean Population
    김경희 Yonsei Medical Journal 45 (5) : 818 ~ 821 [2004]
  • Mutations of the BRAF Gene in Papillary Thyroid Carcinoma in a Korean Population
    김경희 Yonsei Medical Journal 45 5 818-821 [2004]
  • Mutant BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status
    Cradic KW J Clin Endocrinol Metab 94 : 5001 ~ 5009 [2009]
  • Mutant BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status
    Cradic KW J Clin Endocrinol Metab 94 5001-5009 [2009]
  • Management of a solitary thyroid nodule
    Mazzaferri EL N Engl J Med 328 : 553 ~ 559 [1993]
  • Management of a solitary thyroid nodule
    Mazzaferri EL N Engl J Med 328 553-559 [1993]
  • Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy
    Mazzaferri EL Endocr Pract 6 : 469 ~ 476 [2000]
  • Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy
    Mazzaferri EL Endocr Pract 6 469-476 [2000]
  • Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue
    Kwon MJ Pathol Res Pract 207 : 762 ~ 768 [2011]
  • Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue
    Kwon MJ Pathol Res Pract 207 762-768 [2011]
  • Distant metastases from thyroid and parathyroid cancer
    Shaha AR ORL J Otorhinolaryngol Relat Spec 63 : 243 ~ 249 [2001]
  • Distant metastases from thyroid and parathyroid cancer
    Shaha AR ORL J Otorhinolaryngol Relat Spec 63 243-249 [2001]
  • Dietary iodine intake and urinary iodine excretion in normal Korean adults
    Kim JY Yonsei Med J 39 : 355 ~ 362 [1998]
  • Dietary iodine intake and urinary iodine excretion in normal Korean adults
    Kim JY Yonsei Med J 39 355-362 [1998]
  • Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clamping and real-time PCR
    Kang SH Am J Clin Pathol 139 : 759 ~ 764 [2013]
  • Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clamping and real-time PCR
    Kang SH Am J Clin Pathol 139 759-764 [2013]
  • Detectable BRAF mutation in serum DNA samples from patients with papillary thyroid carcinomas
    Chuang TC Head Neck 32 : 229 ~ 234 [2010]
  • Detectable BRAF mutation in serum DNA samples from patients with papillary thyroid carcinomas
    Chuang TC Head Neck 32 229-234 [2010]
  • Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer
    Benbassat CA World J Surg 30 : 1088 ~ 1095 [2006]
  • Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer
    Benbassat CA World J Surg 30 1088-1095 [2006]
  • Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis
    Lee JH Cancer 110 : 38 ~ 46 [2007]
  • Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis
    Lee JH Cancer 110 38-46 [2007]
  • BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study
    Elisei R J Clin Endocrinol Metab 93 : 3943 ~ 3949 [2008]
  • BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study
    Elisei R J Clin Endocrinol Metab 93 3943-3949 [2008]
  • BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications
    Xing M Endocr Rev 28 : 742 ~ 762 [2007]
  • BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications
    Xing M Endocr Rev 28 742-762 [2007]
  • BRAF V600E maintains proliferation, transformation, and tumorigenicity of BRAF-mutant papillary thyroid cancer cells
    Liu D J Clin Endocrinol Metab 92 : 2264 ~ 2271 [2007]
  • BRAF V600E maintains proliferation, transformation, and tumorigenicity of BRAF-mutant papillary thyroid cancer cells
    Liu D J Clin Endocrinol Metab 92 2264-2271 [2007]
  • BRAF (V600E) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR
    Jeong D Ann Surg Oncol 20 : 759 ~ 766 [2013]
  • BRAF (V600E) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR
    Jeong D Ann Surg Oncol 20 759-766 [2013]
  • Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer
    Guan H J Clin Endocrinol Metab 94 : 1612 ~ 1617 [2009]
  • Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer
    Guan H J Clin Endocrinol Metab 94 1612-1617 [2009]
  • Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma
    Lupi C J Clin Endocrinol Metab 92 : 4085 ~ 4090 [2007]
  • Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma
    Lupi C J Clin Endocrinol Metab 92 4085-4090 [2007]
  • Acquisition of BRAF gene mutations is not a requirement for nodal metastasis of papillary thyroid carcinoma
    Trovisco V Clin Endocrinol (Oxf) 69 : 683 ~ 685 [2008]
  • Acquisition of BRAF gene mutations is not a requirement for nodal metastasis of papillary thyroid carcinoma
    Trovisco V Clin Endocrinol (Oxf) 69 683-685 [2008]